Paul Maier has served on our Board of Directors since February 2022. He is a seasoned executive with extensive senior operational, international, and financial management experience, including 25 years in rapid growth pharmaceutical and biotechnology companies. Most recently, Paul was Chief Financial Officer of Sequenom, Inc., from 2009 until 2014. Prior to Sequenom, he spent 15 years at Ligand Pharmaceuticals where he served as the Senior Vice President, Chief Financial Officer. Early in his career, Paul held various financial executive roles at companies such as DFS West and ICN Pharmaceuticals, Inc., and several other private companies.
Paul currently serves on the Board of Directors for Small Pharma Inc., 4D Pharma PLC, Eton Pharmaceuticals, and International Stem Cell Corporation.
Paul received his BS in Business Logistics from Pennsylvania State University and received his MBA from Harvard Graduate School of Business.